Fachrepositorium Lebenswissenschaften

4 Treffer

Suche

Publisso-Menue

Overall survival and adverse events after treatment with darolutamide vs. apalutamide vs. enzalutamide for high-risk non-metastatic castration-resistant prostate cancer: a systematic review and network meta-analysis

2021 . , Mike | Nocera, Luigi | Collà Ruvolo, Claudia | Würnschimmel, Christoph | Tian, Zhe | Özsoy, Mehmet | Saad, Fred | Tilki, Derya | Graefen, Markus | Kluth, Luis A. | Briganti, Alberto | Mandel, Philipp | Montorsi, Francesco | Chun, Felix K. H. | Karakiewicz, Pierre I.

177 Lu-PSMA-617 radioligand therapy of metastatic castration-resistant prostate cancer: Initial 254-patient results from a prospective registry (REALITY Study)

2021 . Khreish, Fadi | Ghazal, Zaidoon | Marlowe, Robert J. | Rosar, Florian | Sabet, Amir | Maus, Stephan | Linxweiler, Johannes | Bartholomä, Mark | Ezziddin, Samer

Early molecular imaging response assessment based on determination of total viable tumor burden in [68Ga]Ga-PSMA-11 PET/CT independently predicts overall survival in [177Lu]Lu-PSMA-617 radioligand therapy

2021 . Rosar, Florian | Wenner, Felix | Khreish, Fadi | Dewes, Sebastian | Wagenpfeil, Gudrun | Hoffmann, Manuela A. | Schreckenberger, Mathias | Bartholomä, Mark | Ezziddin, Samer

Explorative analysis of a score predicting the therapy response of patients with metastatic, castration resistant prostate cancer undergoing radioligand therapy with 177Lu-labeled prostate-specific membrane antigen

2020 . Huang, Kai | Schatka, Imke | Rogasch, Julian M. M. | Lindquist, Randall L. | De Santis, Maria | Erber, Barbara | Radojewski, Piotr | Brenner, Winfried | Amthauer, Holger